Earnings Labs
Rigel Pharmaceuticals, Inc. logo

Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ·Healthcare·Biotechnology

$30.89

+1.25%

Mkt Cap $559.55M

Analyst Ratings

Buy

1

Hold

1

Sell

0

Price Target (4 analysts)

$40.00

Range $38.00$42.00

Implied Upside

+29.5%

Consensus $40.00 vs current $30.89